1. Hayeh SS. The optic nerve circulation in health and disease.
Exp Eye Res 1995;61:259-272.
2. Flammer J, Orgul S. Optic nerve blood-flow abnormalities in glaucoma.
Prog Retin Eye Res 1998;17:267-289.
3. Bresson-Dumont H, Bechetoille A. [Role of arterial blood pressure in the development of glaucomatous lesions].
J Fr Ophtalmol 1996;19:435-442.
4. Cioffi GA, Sullivan P. The effect of chronic ischemia on the primate optic nerve.
Eur J Ophthalmol 1999;9(suppl 1):S34-S36.
5. Costa VP, Harris A, Stefansson E, et al. The effects of antiglaucoma and systemic medications on ocular blood flow.
Prog Retin Eye Res 2003;22:769-805.
6. Hafez AS, Bizzarro R, Descovich D, Lesk MR. Correlation between finger blood flow and changes in optic nerve head blood flow following therapeutic intraocular pressure reduction.
J Glaucoma 2005;14:448-454.
7. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study.
Invest Ophthalmol vis Sci 1985;26:1105-1108.
8. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension. An epidemiological study.
Br J Ophthalmol 1975;59:211-215.
9. Broadway DC, Drance SM. Glaucoma and vasospasm.
Br J Ophthalmol 1998;82:862-870.
10. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension.
J Hypertens 1992;10:875-878.
11. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma.
Br J Ophthalmol 1996;80:864-867.
12. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study.
Ophthalmology 2000;107:1287-1293.
13. Collignon N, Dewe W, Guillaume S, Collignon-Brach J. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression.
Int Ophthalmol 1998;22:19-25.
14. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression.
Surv Ophthalmol 1999;43(Suppl 1):S10-S16.
15. Liu JH. Diurnal measurement of intraocular pressure.
J Glaucoma 2001;10:S39-S41.
16. Tsukahara S, Sasaki T. Postural change of IOP in normal persons and in patients with primary wide open-angle glaucoma and low-tension glaucoma.
Br J Ophthalmol 1984;68:389-392.
17. Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma.
Invest Ophthalmol Vis Sci 2006;47:831-836.
18. Choi J, Kim KH, Jeong J, et al. Circadian Fluctuation of Mean zOcular Perfusion Pressure Is a Consistent Risk Factor for Normal-Tension Glaucoma.
Invest Ophthalmol Vis Sci 2007;48:104-111.
19. Kook MS, Cho HS, Seong M, Choi J. Scanning laser polarimetry using variable corneal compensation in the detection of glaucoma with localized visual field defects.
Ophthalmology 2005;112:1970-1978.
20. Zhou Q, Weinreb RN. Individualized compensation of anterior segment birefringence during scanning laser polarimetry.
Invest Ophthalmol Vis Sci 2002;43:2221-2228.
21. Weinreb RN, Bowd C, Zangwill LM. Glaucoma detection using scanninglaser polarimetry with variable corneal polarization compensation.
Arch Ophthalmol 2003;121:218-224.
22. Verdecchia P, Schillaci G, Porcellati S. Dippers versus non dippers. J Hypertens 1991;9:S42-S44.
23. Hayreh SS, Podhajsky P, Zimmerman MB. Role of nocturnal arterial hypotension in optic nerve head ischemic disorders.
Ophthalmologica 1999;213:76-96.
24. Jampol LM, Board RJ, Maumenee AE. Systemic hypotension and glaucomatous changes.
Am J Ophthalmol 1978;85:154-159.
25. Meyer JH, Brandi-Dohrn J, Funk J. Twenty four hour blood pressure monitoring in normal tension glaucoma.
Br J Ophthalmol 1996;80:864-867.
26. Pannarale G, Pannarale L, Arrico L, et al. Ambulatory blood pressure in patients with glaucoma. Invest Ophthalmol Vis Sci 1996;37:S30.
27. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression.
Surv Ophthalmol 1999;43(Suppl 1):S10-S16.
28. Gramer E, Tausch M. The risk profile of the glaucomatous patient.
Curr Opin Ophthalmol 1995;6:78-88.
29. Berglund G. Goals of antihypertensive therapy, is there a point beyond which pressure reduction is dangerous?
Am J Hypertens 1989;2:586-593.
30. Criuckshank JM, thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure.
Lancet 1987;1(8533):581-583.
31. Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension, is there a point beyond which pressre reduction is dangerous?
JAMA 1991;265:489-495.
32. Rouhiainen HJ, Terasvorta ME. Hemodynamic variables in progressive and non-progressive low tension glaucoma.
Acta Ophthalmol 1990;68:34-36.
33. Riccadonna M, Covi G, Pancera P, et al. Autonomic system activity and 24-hour blood pressure variations in subjects with normal- and high-tension glaucoma.
J Glaucoma 2003;12:156-163.
34. Yazici B, Usta E, Erturk H, Dilek K. Comparison of ambulatory blood pressure values in patients with glaucoma and ocular hypertension.
Eye 2003;17:593-598.
35. Feke GT, Pasquale LR. Retinal Blood Flow Response to Posture Change in Glaucoma Patients Compared with Healthy Subjects.
Ophthalmology 2008;115:246-252.
36. Evans DW, Harris A, Garrett M, et al. Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture change.
Br J Ophthalmol 1999;83:809-813.
37. Leske MC, Heijl A, Hyman L, et al. Predictors of Long-term Progression in the early Manifest glaucoma Trial.
Ophthalmology 2007;114:1965-1972.
38. Fuchsjager-Mayrl G, Wally B, Georgopoulos M, et al. Ocular blood flow and systemic blood pressure in patients with primary open-angle glaucoma and ocular hypertension.
Invest Ophthalmol Vis Sci 2004;45:834-839.
39. Grunwald JE, Piltz JR, Hariprasad SM, Dupont J, Maguire aMG. Optic nerver blood flow in glaucoma: effect of systemic hypertension.
Am J Ophthalmol 1999;127:516-522.
40. Sugiyama T, Utsunomiya K, Ota H, et al. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects.
Am J Ophthalmol 2006;141:394-396.
41. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension.
J Hypertens 1992;10:875-878.
42. Shimada K, Kario K. Altered circadian rhythm of blood pressure and cerebrovascular damage.
Blood Press Monit 1997;2:333-338.
43. Manabe Y, Murakami T, Iwatsuki K, et al. Nocturnal blood pressure dip in CADASIL.
J Neurol Sci 2001;193:13-16.
44. Rufa A, Dotti MT, Franchi M, et al. Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Stroke 2005;36:2554-2558.
45. Aliev G, Obrenovich ME, Seyidova D, de la Torre JC. Exploring ischemia-induced vascular lesions and potential pharmacological intervention strategies.
Histol Histopathol 2005;20:261-273.
46. Reimer KA, Tanaka M, Murry CE, et al. Evaluation of free radical injury in myocardium.
Toxicol Pathol 1990;18:470-480.
47. Sayegh FN, Weigelin E. Functional ophthalmodynamometry: comparison between brachial and ophthalmic blood pressure in sitting and supine position.
Angiology 1983;34:176-182.